Results 11 to 20 of about 235,698 (344)

Social App to Improve Warfarin Therapy in Post-MHVR Chinese Patients: A Randomized Controlled Trial

open access: yesCardiovascular Therapeutics, 2023
Background. Poor anticoagulation quality was a major problem among warfarin-treated patients, which called for innovative and effective methods to improve it. Objective.
Litao Zhang   +10 more
doaj   +1 more source

A re-appraisal of thrombogenesis in COVID-19, seen as a multiple "Complex system"

open access: yesBleeding, Thrombosis and Vascular Biology, 2022
The aim of this essay is to re-consider the peculiar type of thrombogenesis observed in severe cases of COVID-19 infection, focusing on the multiple interconnected networks involved, such as inflammation, blood coagulation, fibrinolysis, and immune ...
Sergio Coccheri
doaj   +1 more source

Antiviral anticoagulation [PDF]

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2020
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel envelope virus that causes coronavirus disease 2019 (COVID-19). Hallmarks of COVID-19 are a puzzling form of thrombophilia that has elevated D-dimer but only modest effects on other parameters of coagulopathy.
Pryzdial, Edward L. G.   +3 more
openaire   +3 more sources

Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

open access: yesBleeding, Thrombosis and Vascular Biology, 2023
The definite diagnosis of antiphospholipid syndrome (APS) depends on the laboratory performance and clinicians’ interpretation. Results from two Italian inception cohort studies of anti-phospholipid antibodies (aPL)-positive subjects, the Italian Survey
Vittorio Pengo   +11 more
doaj   +1 more source

Necrotizing Pancreatitis: To Anticoagulate or Not to Anticoagulate?

open access: yesCureus, 2022
Necrotizing pancreatitis is an inflammatory process that poses a strong risk of systemic venous thromboembolism. However, it is often challenging to opt for systemic anticoagulation since the disease is also associated with an increased risk of hemorrhage.
Abi-Saleh, Simon P   +3 more
openaire   +2 more sources

Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

open access: yesBleeding, Thrombosis and Vascular Biology, 2022
The year 1222 has traditionally been accepted as the University of Padua’s founding date. The University of Padua is a prestigious center for learning and research, and over the centuries, it has produced luminaries in the most significant disciplines ...
Paolo Simioni   +2 more
doaj   +1 more source

Micronized purified flavonoid fraction for the treatment of chronic venous insufficiency, with a focus on postthrombotic syndrome: A narrative review

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2021
Introduction Postthrombotic syndrome (PTS) is a form of secondary chronic venous insufficiency (CVI) that occurs after deep vein thrombosis (DVT). Effective treatments for PTS are lacking.
Ke Xuan Li   +4 more
doaj   +1 more source

Framework Development for Clinical Comprehensive Evaluation of Drugs–a Study Protocol Using the Delphi Method and Analytic Hierarchy Process

open access: yesFrontiers in Pharmacology, 2022
Measuring the value of drugs to help make health-care decisions is a complex process which involves confronting trade-offs among multiple objectives. Although guidelines have been released for clinical comprehensive evaluation of drugs, refinement is ...
Chi Zhang   +10 more
doaj   +1 more source

Cost-Effectiveness Analysis of Direct Oral Anticoagulants Vs. Vitamin K Antagonists in the Elderly With Atrial Fibrillation: Insights From the Evidence in a Real-World Setting

open access: yesFrontiers in Cardiovascular Medicine, 2021
Background: In the clinical setting, the economic benefits of direct oral anticoagulants (DOACs) in elderly patients with atrial fibrillation (AF) remain unclear.
Yue Wu   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy